Pancreatic Cancer: Facing It with Honesty — and Real Hope

No — although it is a serious cancer that is often found late, and it would be wrong to pretend otherwise, it is not hopeless. When it is found early and can be removed by surgery, some people are cured; chemotherapy can sometimes shrink a borderline tumour enough to operate; neuroendocrine tumours often do much better; and even when cure is not possible, treatment and supportive care can control the disease and protect quality of life. A specialist assessment is the best guide to your situation.

Jaundice — yellowing of the eyes or skin, dark urine, pale stools, sometimes with itching — should always be checked promptly. It has many causes, most not cancer, but it needs urgent assessment. If it is pancreatic cancer, jaundice can appear relatively early (from a tumour blocking the bile duct), which sometimes means it is caught while still treatable — and the jaundice itself can be relieved with a stent.

Almost always, no — the vast majority of new diabetes is ordinary type 2 diabetes, not cancer. But new diabetes in an older adult, especially alongside unexplained weight loss rather than weight gain, is occasionally an early clue, so it is worth mentioning any other symptoms to your doctor. Do not panic — but do not ignore weight loss.

Early pancreatic cancer is often silent, and its symptoms can be vague. The most important is jaundice (yellow eyes or skin, dark urine, pale stools). Others include upper-abdominal or back pain, unexplained weight loss, loss of appetite, new-onset diabetes, greasy pale stools, nausea and tiredness. None of these mean cancer on their own — but any that are new and persist for more than a couple of weeks deserve checking.

It depends on whether the tumour can be removed — which is decided by its size, its spread, and its relationship to nearby blood vessels. Some are removable straight away; some borderline tumours can be made removable with chemotherapy first; and some cannot be operated on. A specialist team makes this assessment, which is why a second opinion at a centre that treats pancreatic cancer is worthwhile.

It is the main operation for a tumour in the head of the pancreas — removing the head of the pancreas along with parts of nearby organs, then reconnecting the digestive system. It is major surgery done by specialist hepatobiliary and GI surgeons, which is why CION coordinates it with expert surgical partners while managing your chemotherapy and overall care.

These describe whether a tumour can be removed. Resectable means it can be removed by surgery now. Borderline resectable means it touches nearby blood vessels, so chemotherapy (sometimes with radiation) is usually given first to try to shrink it into the operable group. Locally advanced means it involves major vessels and cannot be removed at present, though treatment can still control it. Metastatic means it has spread to distant organs, where treatment focuses on control and quality of life.

Sometimes, yes. For a borderline tumour that touches nearby blood vessels, chemotherapy given first — occasionally with radiation — can shrink it enough to move it into the removable group. This is called downstaging, and it is one of the most hopeful ideas in pancreatic cancer care. It is why a resectability review by a specialist team, and often a second opinion, is so valuable.

Most pancreatic cancers are ductal adenocarcinoma (PDAC), which starts in the ducts of the pancreas and tends to be aggressive. A much less common group, pancreatic neuroendocrine tumours (pNETs), start in hormone-producing cells, often grow more slowly, and generally have a better outlook — and are treated quite differently. Your exact type is confirmed on a biopsy and guides your plan.

A pNET is an uncommon type of pancreatic cancer that begins in the hormone-producing cells of the pancreas, rather than the ducts. pNETs often grow more slowly than adenocarcinoma and generally have a better outlook. Some are found because they produce hormones; others are found incidentally. They are treated quite differently, so confirming the type is an important first step.

Pancreatic cancer does not have a single cause. Smoking is the biggest modifiable risk; being overweight, heavy alcohol, chronic pancreatitis and long-standing type 2 diabetes also contribute. Older age raises risk, and some people carry an inherited risk through a family history or gene changes such as BRCA or Lynch syndrome. Having a risk factor does not mean you will get pancreatic cancer — and stopping smoking is one of the most useful steps you can take.

Most pancreatic cancer is not inherited, but a minority is linked to a family history or an inherited gene change such as BRCA1, BRCA2 or Lynch syndrome. If pancreatic cancer — or related cancers like breast, ovarian or bowel cancer — runs in your family, genetic counselling can clarify your risk and, where relevant, guide monitoring for close relatives. Everyone’s situation is different, so it is worth discussing with a specialist.

It usually starts with a contrast CT scan, often followed by an MRI or MRCP, and an endoscopic ultrasound that allows a small tissue sample (biopsy) to be taken to confirm the diagnosis. A blood marker called CA 19-9 is used mainly to help monitor treatment rather than to diagnose. A specialist team then reviews all of this to decide whether the tumour can be removed. Because symptoms appear late, prompt assessment matters.

CA 19-9 is a protein that can be raised in the blood in pancreatic cancer. It is useful mainly for monitoring how treatment is working, not as a stand-alone screening or diagnostic test — it can be normal in some pancreatic cancers and raised by harmless conditions such as gallstones or a blocked bile duct. Your doctor interprets it alongside your scans and biopsy.

When a tumour blocks the bile duct and causes jaundice, a small tube called a stent can be placed to reopen the duct and relieve the yellowing, itching and other symptoms. This is done via a coordinated endoscopy procedure and is often one of the first, most helpful steps — it can make you feel much better and help you tolerate other treatment. It is arranged with our gastroenterology and endoscopy partners.

Treatment is planned by a multidisciplinary team and depends on whether surgery is possible. For removable tumours, surgery (the Whipple procedure or distal pancreatectomy, coordinated with specialist HPB/GI surgeons) followed by chemotherapy offers the best chance of cure. Chemotherapy is central throughout — before surgery, after surgery, and as the main treatment for advanced disease — with radiation in selected cases. Supportive care, including jaundice relief and nutrition, runs alongside from the start.

It can be, particularly when it is found early and can be removed by surgery, usually followed by chemotherapy. It is often found late, which makes cure harder — but even then, treatment can control the disease, relieve symptoms and protect quality of life, and chemotherapy can sometimes make surgery possible in borderline cases. Neuroendocrine tumours generally have a better outlook. A specialist assessment is the best guide to what is possible for you.

It varies widely with the stage and treatment — and some treatments (pancreatic surgery or biliary stenting) are delivered at specialist partner centres and may be billed there. It is best given as an indicative range after assessment. Eligible treatment may be covered under Aarogyasri or PMJAY at empanelled centres. Use the cost estimator on this page for an indicative figure, then request a callback for an accurate estimate.

Eligible pancreatic cancer treatment may be largely covered under Aarogyasri and PMJAY at empanelled centres, and cost should not delay care. Our team helps check your eligibility and guides you on private insurance and EMI options. Because some procedures may be delivered at partner centres, we will explain clearly what is covered and where, so there are no surprises.

There is no guaranteed way to prevent pancreatic cancer, but you can lower your risk. Stopping smoking is the single most useful step, as smoking is the biggest modifiable risk factor. Keeping to a healthy weight, limiting alcohol, and managing diabetes also help. For people with a strong family history or a known inherited gene change, genetic counselling can advise on monitoring. Knowing the warning signs — especially jaundice — helps with earlier assessment.